Medprin Regenerative Medical Technologies Co. Ltd. (301033) — Cash Flow Reinvestment Rate
Medprin Regenerative Medical Technologies Co. Ltd. (301033) has a Cash Flow Reinvestment Rate of 0.50x as of December 2024, reinvesting CN¥57.97 Million (capex CN¥33.16 Million plus investments CN¥24.80 Million) from operating cash flow of CN¥116.38 Million. Explore Medprin Regenerative Medical Technologie (301033) capital reinvestment to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Medprin Regenerative Medical Technologies Co. Ltd. Cash Flow Reinvestment Rate (2019–2024)
Historical reinvestment intensity for Medprin Regenerative Medical Technologies Co. Ltd. across 6 annual periods. Also explore Medprin Regenerative Medical Technologie total assets for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Medprin Regenerative Medical Technologies Co. Ltd. (2019–2024)
Year-by-year capital reinvestment analysis for Medprin Regenerative Medical Technologies Co. Ltd.. For live market cap and broader valuation context, see 301033 company net worth.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.50x | CN¥57.97 Million | CN¥116.38 Million | CN¥33.16 Million | ▼ -34.5% |
| 2023 | 0.76x | CN¥81.93 Million | CN¥107.69 Million | CN¥40.09 Million | ▼ -76.2% |
| 2022 | 3.20x | CN¥154.51 Million | CN¥48.31 Million | CN¥135.96 Million | ▼ -54.5% |
| 2021 | 7.03x | CN¥467.64 Million | CN¥66.51 Million | CN¥152.71 Million | ▲ +55.4% |
| 2020 | 4.52x | CN¥153.41 Million | CN¥33.91 Million | CN¥61.65 Million | ▲ +9.7% |
| 2019 | 4.13x | CN¥129.03 Million | CN¥31.27 Million | CN¥36.71 Million | — |